Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes F Mann

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Kidney International|November 28, 2013
How does hemodiafiltration improve survival?Johannes F Mann
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2014
Endothelin antagonism for patients with chronic kidney disease: still a hope for the futureMarkus P Schneider, Johannes F Mann
Kidney International|March 1, 2013
Research needs in the area of device-related treatments for hypertensionJens Jordan, Johannes F Mann, Friedrich C Luft
Neurology(R) Neuroimmunology & Neuroinflammation|January 8, 2015
Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCLElisabeth Schuh, Birgit Ertl-Wagner, Peter Lohse, et al.
Journal of Diabetes and Its Complications|June 21, 2016
LEADER-6: Baseline renal function and associated factors in a high cardiovascular risk type 2 diabetes populationIlhan Satman, Rosangela R Rea, Mats Eriksson, et al.
Plos One|September 20, 2014
A gene variant in CERS2 is associated with rate of increase in albuminuria in patients with diabetes from ONTARGET and TRANSCENDDov Shiffman, Guillaume Pare, Rainer Oberbauer, et al.
Clinical Chemistry|October 20, 2018
A Mendelian Randomization-Based Approach to Identify Early and Sensitive Diagnostic Biomarkers of DiseasePedrum Mohammadi-Shemirani, Jennifer Sjaarda, Hertzel C Gerstein, et al.
Lancet (London, England)|June 4, 2013
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and preventionRon T Gansevoort, Ricardo Correa-Rotter, Brenda R Hemmelgarn, et al.
International Urology and Nephrology|April 21, 2015
Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study)Loreto Gesualdo, Christian Combe, Adrian Covic, et al.
European Journal of Preventive Cardiology|November 6, 2013
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trialHiddo J Lambers Heerspink, Peggy Gao, Dick de Zeeuw, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Kidney International|November 28, 2013
How does hemodiafiltration improve survival?Johannes F Mann
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2014
Endothelin antagonism for patients with chronic kidney disease: still a hope for the futureMarkus P Schneider, Johannes F Mann
Kidney International|March 1, 2013
Research needs in the area of device-related treatments for hypertensionJens Jordan, Johannes F Mann, Friedrich C Luft
Neurology(R) Neuroimmunology & Neuroinflammation|January 8, 2015
Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCLElisabeth Schuh, Birgit Ertl-Wagner, Peter Lohse, et al.
Journal of Diabetes and Its Complications|June 21, 2016
LEADER-6: Baseline renal function and associated factors in a high cardiovascular risk type 2 diabetes populationIlhan Satman, Rosangela R Rea, Mats Eriksson, et al.
Plos One|September 20, 2014
A gene variant in CERS2 is associated with rate of increase in albuminuria in patients with diabetes from ONTARGET and TRANSCENDDov Shiffman, Guillaume Pare, Rainer Oberbauer, et al.
Clinical Chemistry|October 20, 2018
A Mendelian Randomization-Based Approach to Identify Early and Sensitive Diagnostic Biomarkers of DiseasePedrum Mohammadi-Shemirani, Jennifer Sjaarda, Hertzel C Gerstein, et al.
Lancet (London, England)|June 4, 2013
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and preventionRon T Gansevoort, Ricardo Correa-Rotter, Brenda R Hemmelgarn, et al.
International Urology and Nephrology|April 21, 2015
Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study)Loreto Gesualdo, Christian Combe, Adrian Covic, et al.
European Journal of Preventive Cardiology|November 6, 2013
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trialHiddo J Lambers Heerspink, Peggy Gao, Dick de Zeeuw, et al.
Pageof 2